Nsaid-induced Gastroduodenal Injury

• FDA approval · 2023-11-20
  FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Wal-Mart Stores, Inc.)

  The FDA approved Wal-Mart Stores, Inc.'s supplemental application for esomeprazole magnesium, a generic proton pump inhibitor.

• CLINICAL_TRIALS trial_result · 2019-12-26
  Clinical Trial Update: Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury [Phase 2]

  Phase 2 trial of cobiprostone for prevention of NSAID-induced gastroduodenal injury completed with posted results.

• CLINICAL_TRIALS trial_result · 2014-09-30
  Clinical Trial Update: A Multicenter, Double Blinded, Randomized, Parallel Assignment Study to Demonstrate the Efficacy of DA9601 [Phase 4]

  A multicenter, double-blind, randomized Phase 4 trial evaluating DA9601 for NSAID-induced gastroduodenal injury has completed.

• FDA approval · 2014-09-10
  FDA Approved: PANTOPRAZOLE SODIUM — Original Application (XLCare Pharmaceuticals Inc.)

  FDA approves the original abbreviated new drug application for pantoprazole sodium, enabling a generic pantoprazole product from XLCare Phar…